Based on innovations from Harvard University and Boston Children's Hospital, Nocion Therapeutics aims to selectively silence pain and itch neurons

Developed through Harvard’s Blavatnik Biomedical Accelerator, innovations could lead to novel cell therapies to treat disease

Synthetic biology-based diagnostic platform enables low-cost, highly sensitive detection of nucleic acids in a wide range of settings

Harvard researchers' startup, which uses machine learning to design and test chemical compounds, is profiled in Technology Review